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(N = 10) (N = 5) P
Mean (SD)
Age (yrs) 67.9 (9.4) 67.6 (10.9) 68.4 (6.3) 0.88
Body mass index (kg/m2) 23.1 (4.6) 23.7(4.9) 22.1(4.2) 0.52
N (%)
Sex
M 9 (60) 4 (40) 5 (100)
F 6 (40) 6 (60) 0 (0) 0.04
PS
1 2 (13) 2 (20) 0 (0)
2 6 (40) 4 (40) 2 (40)
3 7 (47) 4 (40) 3 (60) 0.79
Diagnosis
Lung Cancer 4 (27) 3 (30) 1 (20)
GI cancer 6 (40) 2 (20) 4 (80)
Other 5 (33) 5 (50) 0 (0) NA
Cancer stage
III 1 (7) 1 (10) 0 (0)
IV 11 (73) 6 (60) 5 (100)
NA 3 (20) 3 (30) 0 (0) NA
Chemotherapy
Y 10 (67) 6 (60) 4 (80)
N 5 (33) 4 (40) 1 (20) 0.60
Recent steroid use
Y 6 (40) 4 (40) 2 (40)
N 9 (60) 6 (60) 3 (60) 1.00
Notes: P indicates result of significance testing (unpaired t-test for means or Fisher’s exact test for count data) comparing patients who did, or did not complete the study.
Table 2 Physical performance evaluation results at baseline and after 6 weeks of NMES intervention




(N = 5) (N = 10) Pa (N = 10) Difference Pb
Number
PS 1 0 2 0.79# 4 0.15#
2 2 4 4
3 3 4 2
Mean (SD)
6MWT m 257(160) 166 (138) 303 (157) 0.11 282 (171) −21.1 (167.7) 0.70
% 50.2 (32.2) 31.0(24.6) 59.8(32.2) 0.08 56.0(34.5) −3.8 (33.3) 0.73
STS s 8.0(4.3) 7.6 (3.4) 8.2 (4.8) 0.80 7.0(3.3) −1.2 (3.4) 0.30
S-score 2.6(2.4) 2.2 (2.0) 2.7 (2.2) 0.69 2.0(1.8) −0.7 (2.0) 0.30
Notes: Performance status (PS), six-minute walk distance (6MWT) in metres (m) and expressed as % predicted (from [21]), Sit-to-stand (STS) test expressed as seconds (s)
and as a standard score (S-score) value calculated using age range-specific mean and standard deviations for healthy controls (from [22]): positive scores indicates STS
S-scores above the mean. Pa: #Fisher’s exact (for counts) or unpaired t-test (for means) comparing baseline results for patients withdrawn and patients who completed
study. Pb: #Fisher’s exact (for counts) or paired t-test (for means) comparing baseline and final test results for patients who completed the study.
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